All lobbying filings

Cavarocchi Ruscio Dennis Associates, L.L.C.

Cavarocchi Ruscio Dennis Associates, L.L.C. filed a Q1 report for Hereditary Hemorrhagic Telangiectasia Foundation on April 15, 2026, reporting $10,000 in lobbying income.

Lobbying for Hereditary Hemorrhagic Telangiectasia Foundation · patient advocacy organization for individuals suffering from a rare disease

As filed: CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. for HEREDITARY HEMORRHAGIC TELANGIECTASIA FOUNDATION.

All filings by Cavarocchi Ruscio Dennis Associates, L.L.C. · Everything Hereditary Hemorrhagic Telangiectasia Foundation has reported

Filing · LD-2 quarterly report Q1 report

Reporting period

1st Quarter 2026

Jan 1 - Mar 31 · Posted Apr 15, 2026

Income

$10,000

What the client paid this registrant for the period.

Client based in

Maryland

Official filing document

Government bodies contacted 2

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

Lobbying activity 2

Defense

Hereditary Hemorrhagic Telanglectasia (HHT)

Health Issues

H.R. 7148, FY 2026 Consolidated Appropriations Act, Peer Reviewed Medical Research Program designation for Hereditary Hemorrhagic Telangiectasia (HHT) and Funding for National HHT Center of Excellence Program; H.R./S. Unnumbered, FY 2027 Defense Appropriations Act, Peer Reviewed Medical Research Program designation for Hereditary Hemorrhagic Telangiectasia (HHT); H.R./S. Unnumbered, FY 2027 Labor-HHS-Education Act, Funding for National HHT Center of Excellence Program

Bills named in this filing 1

H.R. 7148
Consolidated Appropriations Act, 2026

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.